OSM and intrahepatic cholangiocarcinoma: In terms of mechanism, OSM (oncostatin M), which is preferentially expressed by TANs, and IL-11, which is preferentially expressed by TAMs, jointly activate STAT3 signaling in ICC (intrahepatic cholangiocarcinoma) cells, thus achieving the tumor promoting effect [101].